Fig. 10From: Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceTime response of Sch B treatment on hepatocyte ultrastructure. Experimental details were described in Fig. 1. Mice were orally administered with Sch B (1 g/kg). Control (untreated) animals received the vehicle only. After 72 and 120 h, mice were sacrificed and liver tissues were removed and fixed in 2% glutaraldehyde Sorensen’s phosphate buffer. Then ultrathin sections were made and stained with uranyl acetate and lead citrate for TEMBack to article page